Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

The POU4F2/Brn-3b transcription factor is required for the hypertrophic response to angiotensin II in the heart.

Mele L, Maskell LJ, Stuckey DJ, Clark JE, Heads RJ, Budhram-Mahadeo VS.

Cell Death Dis. 2019 Aug 14;10(8):621. doi: 10.1038/s41419-019-1848-y.

2.

Loss of Protein Kinase Novel 1 (PKN1) is associated with mild systolic and diastolic contractile dysfunction, increased phospholamban Thr17 phosphorylation, and exacerbated ischaemia-reperfusion injury.

Francois AA, Obasanjo-Blackshire K, Clark JE, Boguslavskyi A, Holt MR, Parker PJ, Marber MS, Heads RJ.

Cardiovasc Res. 2018 Jan 1;114(1):138-157. doi: 10.1093/cvr/cvx206.

3.

Essential but partially redundant roles for POU4F1/Brn-3a and POU4F2/Brn-3b transcription factors in the developing heart.

Maskell LJ, Qamar K, Babakr AA, Hawkins TA, Heads RJ, Budhram-Mahadeo VS.

Cell Death Dis. 2017 Jun 8;8(6):e2861. doi: 10.1038/cddis.2017.185.

4.

Expression and regulation of type 2A protein phosphatases and alpha4 signalling in cardiac health and hypertrophy.

Eleftheriadou O, Boguslavskyi A, Longman MR, Cowan J, Francois A, Heads RJ, Wadzinski BE, Ryan A, Shattock MJ, Snabaitis AK.

Basic Res Cardiol. 2017 Jul;112(4):37. doi: 10.1007/s00395-017-0625-2. Epub 2017 May 19.

5.

An ongoing role of α-calcitonin gene-related peptide as part of a protective network against hypertension, vascular hypertrophy, and oxidative stress.

Smillie SJ, King R, Kodji X, Outzen E, Pozsgai G, Fernandes E, Marshall N, de Winter P, Heads RJ, Dessapt-Baradez C, Gnudi L, Sams A, Shah AM, Siow RC, Brain SD.

Hypertension. 2014 May;63(5):1056-62. doi: 10.1161/HYPERTENSIONAHA.113.02517. Epub 2014 Feb 10.

PMID:
24516108
6.

Protein kinase Cε-calcineurin cosignaling downstream of toll-like receptor 4 downregulates fibrosis and induces wound healing gene expression in cardiac myofibroblasts.

Mesquita RF, Paul MA, Valmaseda A, Francois A, Jabr R, Anjum S, Marber MS, Budhram-Mahadeo V, Heads RJ.

Mol Cell Biol. 2014 Feb;34(4):574-94. doi: 10.1128/MCB.01098-13. Epub 2013 Dec 2.

7.

Hsp-27 induction requires POU4F2/Brn-3b TF in doxorubicin-treated breast cancer cells, whereas phosphorylation alters its cellular localisation following drug treatment.

Fujita R, Ounzain S, Wang AC, Heads RJ, Budhram-Mahadeo VS.

Cell Stress Chaperones. 2011 Jul;16(4):427-39. doi: 10.1007/s12192-011-0256-8. Epub 2011 Jan 29.

8.

Proliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ERα and growth factors via MAPK pathway.

Ounzain S, Bowen S, Patel C, Fujita R, Heads RJ, Budhram-Mahadeo VS.

Breast Cancer Res. 2011 Jan 17;13(1):R5. doi: 10.1186/bcr2809.

9.

MAPKAPK-2 modulates p38-MAPK localization and small heat shock protein phosphorylation but does not mediate the injury associated with p38-MAPK activation during myocardial ischemia.

Gorog DA, Jabr RI, Tanno M, Sarafraz N, Clark JE, Fisher SG, Cao XB, Bellahcene M, Dighe K, Kabir AM, Quinlan RA, Kato K, Gaestel M, Marber MS, Heads RJ.

Cell Stress Chaperones. 2009 Sep;14(5):477-89. doi: 10.1007/s12192-009-0101-5. Epub 2009 Feb 13.

10.

Cardiac expression of Brn-3a and Brn-3b POU transcription factors and regulation of Hsp27 gene expression.

Farooqui-Kabir SR, Diss JK, Henderson D, Marber MS, Latchman DS, Budhram-Mahadeo V, Heads RJ.

Cell Stress Chaperones. 2008 Sep;13(3):297-312. doi: 10.1007/s12192-008-0028-2. Epub 2008 Mar 27.

11.

Protein sulfenation as a redox sensor: proteomics studies using a novel biotinylated dimedone analogue.

Charles RL, Schröder E, May G, Free P, Gaffney PR, Wait R, Begum S, Heads RJ, Eaton P.

Mol Cell Proteomics. 2007 Sep;6(9):1473-84. Epub 2007 Jun 14.

12.

Post-infarction remodeling is independent of mitogen-activated protein kinase kinase 3 (MKK3).

Clark JE, Flavell RA, Faircloth ME, Davis RJ, Heads RJ, Marber MS.

Cardiovasc Res. 2007 Jun 1;74(3):466-70. Epub 2007 Feb 28.

PMID:
17399693
13.

Calcineurin regulates NFAT-dependent iNOS expression and protection of cardiomyocytes: co-operation with Src tyrosine kinase.

Obasanjo-Blackshire K, Mesquita R, Jabr RI, Molkentin JD, Hart SL, Marber MS, Xia Y, Heads RJ.

Cardiovasc Res. 2006 Sep 1;71(4):672-83. Epub 2006 Jun 3.

PMID:
16828070
14.

IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes.

Smart N, Mojet MH, Latchman DS, Marber MS, Duchen MR, Heads RJ.

Cardiovasc Res. 2006 Jan;69(1):164-77. Epub 2005 Oct 10.

PMID:
16219301
15.

Expression of the Brn-3b transcription factor correlates with expression of HSP-27 in breast cancer biopsies and is required for maximal activation of the HSP-27 promoter.

Lee SA, Ndisang D, Patel C, Dennis JH, Faulkes DJ, D'Arrigo C, Samady L, Farooqui-Kabir S, Heads RJ, Latchman DS, Budhram-Mahadeo VS.

Cancer Res. 2005 Apr 15;65(8):3072-80.

16.

Regulation of Hsp27 expression and cell survival by the POU transcription factor Brn3a.

Farooqui-Kabir SR, Budhram-Mahadeo V, Lewis H, Latchman DS, Marber MS, Heads RJ.

Cell Death Differ. 2004 Nov;11(11):1242-4. No abstract available.

17.

Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia.

Tanno M, Bassi R, Gorog DA, Saurin AT, Jiang J, Heads RJ, Martin JL, Davis RJ, Flavell RA, Marber MS.

Circ Res. 2003 Aug 8;93(3):254-61. Epub 2003 Jun 26.

PMID:
12829618
18.

The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes.

Saurin AT, Martin JL, Heads RJ, Foley C, Mockridge JW, Wright MJ, Wang Y, Marber MS.

FASEB J. 2000 Nov;14(14):2237-46.

PMID:
11053245
19.
20.

PKC-dependent delayed metabolic preconditioning is independent of transient MAPK activation.

Mockridge JW, Punn A, Latchman DS, Marber MS, Heads RJ.

Am J Physiol Heart Circ Physiol. 2000 Aug;279(2):H492-501.

21.

IGF-1 regulates cardiac fibroblast apoptosis induced by osmotic stress.

Mockridge JW, Benton EC, Andreeva LV, Latchman DS, Marber MS, Heads RJ.

Biochem Biophys Res Commun. 2000 Jun 24;273(1):322-7.

PMID:
10873605
22.

Activation of Akt during simulated ischemia/reperfusion in cardiac myocytes.

Mockridge JW, Marber MS, Heads RJ.

Biochem Biophys Res Commun. 2000 Apr 21;270(3):947-52.

PMID:
10772931
23.

Differential protection of primary rat cardiocytes by transfection of specific heat stress proteins.

Cumming DV, Heads RJ, Watson A, Latchman DS, Yellon DM.

J Mol Cell Cardiol. 1996 Dec;28(12):2343-9.

PMID:
9004151
24.

Oxidative stress and the second window of protection after preconditioning.

Baxter GF, Heads RJ, Yellon DM.

Circulation. 1996 Dec 1;94(11):2992-3. No abstract available.

PMID:
8941138
25.

Pharmacological preconditioning of primary rat cardiac myocytes by FK506.

Cumming DV, Heads RJ, Coffin RS, Yellon DM, Latchman DS.

Basic Res Cardiol. 1996 Sep-Oct;91(5):367-73.

PMID:
8922254
26.

Infarct limitation of the second window of protection in a conscious rabbit model.

Yang XM, Baxter GF, Heads RJ, Yellon DM, Downey JM, Cohen MV.

Cardiovasc Res. 1996 May;31(5):777-83.

PMID:
8763407
27.

Myocardial protection after monophosphoryl lipid A: studies of delayed anti-ischaemic properties in rabbit heart.

Baxter GF, Goodwin RW, Wright MJ, Kerac M, Heads RJ, Yellon DM.

Br J Pharmacol. 1996 Apr;117(8):1685-92.

28.
29.

The ability of heat stress and metabolic preconditioning to protect primary rat cardiac myocytes.

Cumming DV, Heads RJ, Brand NJ, Yellon DM, Latchman DS.

Basic Res Cardiol. 1996 Jan-Feb;91(1):79-85.

PMID:
8660264
30.
31.
32.
34.
35.

A biosynthetic study of meprin: a mouse renal microvillar membrane metallo-endopeptidase.

Heads RJ, Beynon RJ.

Biochem Soc Trans. 1990 Oct;18(5):1026-7. No abstract available.

PMID:
2083647
36.

Differential synthesis of histone H1 during early spherulation in Physarum polycephalum.

Heads RJ, Carpenter BG.

Biochim Biophys Acta. 1990 Jun 12;1053(1):56-62.

PMID:
2114182

Supplemental Content

Loading ...
Support Center